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Abstract 
Agricultural biotechnology is a growing industry that creates many 
benefits. Through plant and animal science, this industry improves efficiency and 
reduces costs for agriculture by researching genetics of plants and animals and 
creating changes in the DNA to produce higher quality, higher production crops 
and livestock. Biotechnology also helps the agricultural industry by improving 
food processing, bioremediation, and biomass conversion practices. 
This study researches agricultural biotechnology firms in the United 
States. It reviews revenue, employment, research and development, financing, 
and products marketed and products in development. This thesis analyzes any 
possible relationships between the agricultural industry and the biotechnology 
industry. 
The amount of revenue and employees of agricultural biotechnology 
companies is very high, showing the importance of biotechnology in America. 
However, no substantial link relates the agricultural industry and biotechnology. 
Agricultural biotechnology is widely dispersed across the nation and is not 
dependent on the amount of agriculture in each state. For example, Idaho and 
Wyoming have no agricultural biotechnology firms while Massachusetts has 36 
firms and New Jersey has 33 firms. 
The firms' product emphasis varies, but most firms focus on plant input 
and animal input characteristics, such as herbicide and insect resistance and 
vaccines, and focus on bioprocessing involving the improvement of food 
processing. The least amount of product emphasis included plant and animal 
output characteristics because these are in their early stages of development. 
There are no trends between states in regards to the averages of each 
firm's revenue, employment, and research and development per state. Each 
state varies substantially in total amounts and average amounts per firm. 
Introduction 
"Biotechnology is, without a doubt, one of the most precocious of 
discoveries, quickly moving into the center of biological sciences. It is providing 
for new products which promise to add much to commerce and industry, 
including specific biomedical therapies and dramatically improved agricultural 
practices and products" (National Agricultural Biotechnology Council, 1993, p. 
13). 
Agricultural biotechnology is the scientific alteration of the genetics of 
crops, livestock, and food processing to allow for greater productivity and/or 
production. Agricultural biotechnology includes techniques such as: recombinant 
DNA, gene transfer, embryo manipulation and transfer, plant regeneration, tissue 
culture, monoclonal antibodies, and bioprocess engineering (Baumgardt and 
Marshall, p.3). 
Agricultural biotechnology began with Gregor Mendel, who cross-
pollinated pea plants to discover the dominant and recessive genes that plants 
carry. Mendel's research created the foundation for the discovery and analysis 
of DNA, and, therefore, the advent of genetic engineering (Baumgardt and 
Marshall, pp. 9-12). 
Today, agricultural biotechnology creates tremendous opportunities for 
American agriculture. In the area of plant science, biotechnology aids crops 
through increased insect and disease control, new approaches to weed control, 
improved resistance to environmental stress factors, more efficient use of 
nutrients, improved product quality, and improvements in plant metabolic 
characteristics (Baumgardt and Marshall, p.13). In 1998 genetically modified 
corn, cotton, and soybean crops accounted for 20 to 44 percent of the acreage 
planted (United States Department of Agriculture). The following table 
represents some of the biotechnology that is affecting plant science: 
PRODUCT 
tomatoes, peas. peppers, 
tropical fruit, broccoli, 
raspberries, melons 
tomatoes, potatoes, corn, 
lettuce, coffee, cabbage 
family, apples 
. !>E'r:>per.§_,_lomatoes, 
potatoes, tomatoes, 
cantaloupe, squash, 
cucumbers, corn, oilseed 
rape (canola), soybeans, 
grapes 
soybeans tomatoes, corn, 
oilseed rape (canota), 
wheat 
corn, sunflowers, 
soybeans, and other plants 
oilseed rape (canola), palm 
(date, oil or heart) 
oilseed rape (canola), 
peanuts 
coffee 
corn, peas 
controlled ripening 
insect resistance 
fiJngal re~stancE:) 
viral resistance 
herbicide tolerance 
improved nutrition 
improved nutrition 
heat stability 
low caffeine content 
controlled starch 
Source: Food Marketing Institute, 2000 
PURPOSE 
Allow shipping of 
vine-ripened tomatoes; 
improve quality, shelf life, 
food processing 
Reduce insecticide use 
RediJ~ th.E:~_ fungicide u~E:l ~ 
Reduce diseases caused 
, by plant viruses and, since 
insects carry viruses, 
reduce insecticide use 
Improve weed control 
Increase the amount of 
essential amino acids, 
vitamins or other nutrients , 
Increase the amount of 
unsaturated oils in the 
plant by altering the 
oil-producing pathway______ 
Improve processing quality;, 
permit new food uses for ' 
healthier oils 
Naturally decaffeinate 
Retain sweetness during 
entire shelf life 
Biotechnology in animal science has also created many opportunities. 
These opportunities include: improved efficiency and quality and improved 
lactation and growth, reproduction, health, and genetics (Baumgardt and 
Marshall, p. 16) 
Burrus and Thomsen argued that the keys to American success in 
agriculture include: "decreasing the farmers' input cost per unit of output, 
increasing the farmers' product yield on a per acre basis and per dollar of 
invested capital, and increasing the consumers' demand for agricultural products" 
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(Burrus and Thomsen, p. ii). American farmers are able to achieve these through 
biotechnology because of improved production and efficiency and reduced costs 
through less need for herbicides, insecticides, vaccines, etc. 
Agricultural biotechnology has many benefits. It helps the environment 
through less need for chemicals. Biotechnology increases production and, 
therefore, increases the amount food to support the world's growing population. 
This technology improves nutrition, quality, and taste, which may help reduce 
cancer and heart disease. Biotechnology allows for the creation of better drugs 
and vaccines to promote healthier living around the world. Agricultural 
biotechnology will, in the future, allow for less need of natural resources. 
(Council for Biotechnology Information, 2000). 
Agricultural biotechnology opens doors for American farmers. Farmers 
are able to increase their productivity and quality of their products while lowering 
their costs. As all farmers in America adopt biotechnology products, this 
increase in quality and production and decrease in costs will allow America's 
competitiveness in agriculture to increase when compared to other nations 
around the world. Increased competitiveness will allow American farmers to 
increase their revenues, which is important given the lackluster performance of 
commodity prices over the last decade. 
Problem Identification and Justification 
Although agricultural biotechnology is an increasingly important American 
industry, little research has been done to discover the product and research 
development that American biotech firms undertake. 
This study will research the United States agricultural technology firms to 
analyze the products, revenues and expenses, research and development, 
number of employees, amount in budget, products in development, products 
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marketed, and financing. This analysis will create a better understanding of 
agricultural biotechnology firms in America today. 
Objectives 
1) to discover what agricultural biotechnology companies are in America 
2) to find what these companies' products are, including new product 
research and development 
3) to determine where these firms are, and if there are any trends in location 
of agricultural biotechnology 
4) to determine the amount of revenues and research and development that 
these firms undertake 
5) to determine the number of employees in each firm, and determine the 
number of those employees committed to research and development of 
new products 
6) to find any possible correlations between the agricultural biotechnology 
industry and the agriculture sector of the American economy 
Through this research, I hope to learn about biotechnology and the new 
products developed and soon to be developed. I would like to see correlations 
between states in the amount of research facilities and the amount of money 
invested in these firms. I would like to determine if biotechnology research is 
regional or spread throughout the United States. Biotechnology is a scientific 
phenomenon that could create drastic changes in the way we live, breathe, and 
eat in the near future. It is important that Americans are informed about the new 
technologies, and the new products developed from those technologies, to be 
able to make knowledgeable purchasing decisions based on quality and safety. 
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Procedures and Methods 
1) Gather Research 
Most of the research was gathered online from the Institute of 
Biotechnology Information through a subscription provided by Dr. Thomas 
Sporleder of the Ohio State University. The Institute of Biotechnology 
Information supplies data about companies for each state and for the United 
States as a whole. Information supplied by this research facility includes: 
company name, address, state, revenue, revenue for biotechnology, R&D 
budget, R&D expenditures, number of employees, number of biotech employees, 
company type, biotech industry classification, technologies used, products in 
development, products on the market, etc. (Institute of Biotechnology 
Information). 
Information was, also, gathered through FedStats, an online government 
source for factual statistics for the United States as a whole, regions of the U.S., 
and the fifty states. The statistics gathered from this source included: jobs per 
state, percent employment in the agricultural sector per state, total farmland per 
state, total cropland per state, crop output per state, animal output per state, 
services and forestry output per state, total agriculture sector output per state, 
and net farm income per state. 
Gross state product (GSP) was gathered through the Bureau of Economic 
Analysis of the United States government. These statistics were for 1997 GSP 
for every state. 
The gathering of information consumed a great deal of time. Information 
gathering began in October of 1999. First, I gathered information from the 
Institute for Biotechnology Information. I realized that some states were not 
listed on the database. I needed to wait until March, when the database was 
properly updated, to gather all appropriate information. 
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2) Analyze Data 
Analysis began in November, before I realized that there was missing 
information. I began to analyze each state's biotechnology firms, studying their 
financing, revenue, employment, and research and development. All of this 
information had to be thrown out. Missing information was not the cause of 
throwing out the data analysis; the cause was due to human error. I analyzed 
1286 biotechnology firms that were categorized under "agriculture" and 
"biotechnology." However, this did not mean that I was studying agricultural 
biotechnology companies. It meant that I was studying general biotechnology 
firms and agricultural biotechnology firms. 
Upon further research, I discovered that many of the firms categorized as 
general biotechnology had links to agriculture. Also, the database included other 
categories of company type that dealt with agriculture (chemical, diagnostics, 
energy, food, instruments, pharmaceutical, research, veterinary, and waste). 
gathered all of this information and began new data analysis. 
I began by categorizing all the products in development and products on 
the market of each firm with over 1400 firms. I categorized these in order to 
identify the firms with agricultural interests. The categories included: plant 
genomics, animal genomics, plant input characteristics, plant output 
characteristics, plant efficiency characteristics, animal input characteristics, 
animal output characteristics, animal efficiency characteristics, bioprocessing, 
bioremediation and environmental testing, biomass conversion, and aquaculture. 
These categories were provided by An Initial Economic Assessment of 
Agricultural Biotechnology in Ohio. Another category, agriculture for medical 
purposes, was added. Below gives a description of each category (Sporleder, 
1999). 
•!• Plant Genomics: The function, features, and location of genes in plants. 
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•!• Animal Genomics: The function, features, and location of genes in animals. 
•!• Plant Input Characteristics: Any biotechnology that results in adding value 
through influencing the input characteristics of the commercial product or 
services. Herbicide tolerance or insect resistance are example application 
technologies in this category. Specifically, Roundup Ready soybeans alter 
the characteristics of the input (the seed) compared to conventional seed 
beans. Another example is a genetically modified seed corn that provides the 
plant protection against disease. As a specific example, NatureGard™ hybrid 
seed corn by Mycogen offers the plant resistance to the European corn borer. 
•:• Plant Output Characteristics: Any biotechnology that results in adding value 
through influencing the output characteristics of the commercial product or 
service. For example, high-lysine corn alters the output characteristics of the 
commodity that is sold relative to conventional No.2 yellow corn. Similarly, 
low linolenic soybean oil possesses enhanced stability, reducing the need for 
chemical hydrogenation, which ultimately results in reduced transfatty acids in 
the target processed product. Yet another example is an edible vaccine bred 
into genetically modified potatoes or bananas, which results in immunity to 
certain human disease. 
•!• Plant Efficiency Characteristics: Any biotechnology that results in adding 
value through influencing the efficiency or agronomic characteristics of the 
commercial product or service. For example, a biotechnology that results in 
grater yield per acre for a commodity would be categorized here. Included in 
this broad class are technologies that result in enhanced efficiency in food 
processing. Genetically modified tomatoes that result in higher yield of solids 
in the processing plant is another example of altering the commodity (in this 
case the tomato) for enhanced efficiency in processing. As an additional 
specific example, Chy MaxTM by Pfizer is a fermentation-derived version of 
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the enzyme chymosin used in making hard cheeses. This product offers 
processors advanced fermentation of higher purity, quality, and activity than 
natural rennet. 
•!• Animal Input Characteristics: Any biotechnology that results in adding value 
through influencing the input characteristics of the commercial product or 
service. For example, animal health technologies that may be classified as 
veterinary vaccines or biologics are in this category. A transgenic animal that 
is resistant to disease or experiences an improved health status (e.g. pigs 
resistant to scours). 
•!• Animal Output Characteristics: Any biotechnology that results in adding value 
through influencing the output characteristics of the commercial product or 
service. Genetically modified animals to produce an enhanced quality of 
meat (e.g. less fat per pound of lean) would be an example. 
•!• Animal Efficiency Characteristics: Any biotechnology that results in adding 
value through influencing the efficiency or yield characteristics of the 
commercial product or service. Reproduction technologies such as 
superovulation and in vitro fertilization would be examples within this 
category. For example, growth promotants such as bovine somatotropin or 
swine somatotropin (bST and pST, respectively) represent early 
biotechnologies that result in greater efficiency in the sense of more output 
per unit of input. For dairy operations, bST results in increased output of milk 
per cow. Similarly, transgenic animals that result in greater meat per pound 
of feed fed, or other efficiency criteria, would also be part of this category. 
•!• Bioprocessing: Often popularly called "pharming," this is a broad class of 
technologies that use microbial, plant, or animal cells for the production of 
chemical compounds. Bioprocessing exploits several biological phenomena 
ranging from fermentation to the production of enzymes, amino acids, and 
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biocatalysts. Using bovines as bioreactors to harvest body fluids of potential 
value in the human health market is an example of bioprocessing. Also 
included here are process monitoring and control methods developed 
specifically for bioprocessing. The monitoring and control of manufacturing 
processes requires information feedback from every critical step in the 
bioprocess. Examples are biosensors that operate automatically and are 
environmentally benign during the manufacturing processes or allow the 
detection, monitoring, and control of food additives, food safety factors, and 
bioremediation technologies. Bioprocessing potentially influences industries 
ranging from food production, pharmaceutical, chemical and even mining 
industries. 
•!• Bioremediation and Environmental Testing: This area is a class of 
applications that endeavor to use biotechnology to assess and improve the 
well-being of ecosystems, transform pollutants into benign substances, 
generate biodegradable materials from renewable sources, and/or develop 
environmentally safe manufacturing and disposal processes. Different types 
of organisms can be bioremediation agents. For example, plants can be used 
to concentrate pollutants. More common, however, is bioremediation by 
microorganisms. Microorganisms (primarily bacteria and fungi) naturally 
recycle. They are capable of transforming natural and synthetic chemicals 
into sources of energy and raw materials for their own growth. 
Bioremediation through microorganisms involves replacing or supplementing 
chemical processes with biological processes that may be lower in costs and 
more environmentally benign. 
•!• Biomass Conversion: Biomass uses biological processes .to produce organic 
polymeric material, such as lignin, starches, cellulose, and oil. Plants and 
algae are the primary stock for biomass conversion. Possible, but less 
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important, additional sources of biomass stock include food processing waste, 
waste paper, and municipal solid waste. 
•!• Aquaculture: Any biotechnology that results in adding value through 
influencing the commercial products from marine animals. Genetically 
modified fish may enhance the human food supply. 
•!• Agriculture for Medical Purposes: Any biotechnology that uses plants and/or 
animals in order to aid human health. An example of this category would 
include animal organs implanted into humans to increase human survival. 
It should be noted that most firms were listed in more than one category 
because these firms develop and market many different products which fall into 
different categories. 
Once all products were categorized, I studied the "biotechnology 
industries" category on the Institute for Biotechnology Information to determine 
that all firms were properly categorized. I, then, removed all biotechnology firms 
with no emphasis on agriculture. 
The following categories were all focused on during the data analysis: 
number of companies per state, state, employees per state, biotech employees 
per state, financing (private or public) per state, revenue of biotech firms per 
state, biotech revenue of biotech firms per state, research and development 
budget of biotech firms per state, research and development biotech budget of 
biotech firms per state, number of biotech firms in the thirteen product categories 
referred to above, average employees per firm per state, average biotech 
employees per firm per state, average revenue per firm per state, average 
biotech revenue per firm per state, average R&D per firm per state, average R&D 
biotech per firm per state, revenue per employee per state, R&D per dollar of 
revenue, percent biotech employees, percent biotech revenue, percent biotech 
R&D (all obtained from the Institute of Biotechnology Information, 2000). 
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Number of jobs per state (1997), percent agricultural jobs per state (1996), 
total land per state (1997), farmland per state (1997), percent farmland of total 
land per state (1997), cropland per state (1997), percent cropland of farmland per 
state (1997), crop output per state (1998), animal output per state (1998), 
services and forestry output per state ( 1998), total output per state ( 1998), net 
farm income (1998) were obtained from FedStats and focused on. Gross State 
Product (abbreviated GSP, 1997) was found at the Bureau of Economic Analysis 
and was integrated into the research. 
The following calculations were made based upon the statistics listed 
above: total agricultural output per state compared to total revenue per state, 
GSP compared to revenue per state, GSP compared to net farm income per 
state, number of jobs per state compared to employees of biotech firms per state, 
number of jobs per state compared to biotech employees of biotech firms per 
state, and employees of biotech firms compared to biotech employees of biotech 
firms per state. The calculations included: adjusted R squared and standard 
error as well as correlation and standard deviation. These calculations were 
made in order to see possible relationships between the two features compared. 
3) Draw Conclusions Based on Analysis 
The results of the data analysis were derived from the information and 
calculations. The results of correlations and adjusted R squared were expected 
to be low, and standard deviation and standard error were expected to be high. 
In other words, no relationships were expected between any features compared. 
Microsoft Excel was the statistical software used to determine the calculations. 
Tables and charts are supplied in the Appendix of this thesis to aid in the 
understanding of the trends of the data analysis. The Results/Discussion section 
will analyze these results. 
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Results/Discussion 
A total of 573 biotechnology firms are agriculturally related. These firms 
are located in 43 states as well as Washington D.C.. 359 of these firms are 
funded privately while 174 are funded publicly. These firms collectively have 
almost one million employees, $260 billion in revenue, and $14 billion budgeted 
for R&D (refer to Table 1 in Appendix). These figures are astounding and show 
the importance of agricultural biotechnology in this country. 
However, when looking at the dispersion of agricultural biotech firms, 
there is no prominent central location for this biotechnology research. It seems 
to be widely spread across the United States (refer to United States map in 
Appendix). California has the most agricultural biotechnology firms with 81. 
However, most states have under twenty firms (refer to Table 1 in Appendix). 
There are almost double the amount of private agricultural biotechnology 
firms as there are public firms (refer to Table 1 in Appendix). This represents a 
great deal of independent research used to manufacture specific products with 
detailed features. There seems to be no trends depending on location of the 
firms and their type of financing. 
It is surprising to see that California, with almost two and a half times more 
firms than New Jersey, has five times less revenue than New Jersey. This may 
partially be due to firms not reporting their revenues to the Institute for 
Biotechnology Information. Also, these firms may not have revenues because 
they are new to the market and have no products to sell. They may need 
tremendous research and development before products can be developed and 
marketed. California does have a greater biotech R&D budget compared to the 
other states (refer to Table 1 in Appendix). 
Animal input characteristics and plant input characteristics as well as 
bioprocessing seem to be the focus of many biotech firms {refer to Table 2 in 
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Appendix). Many companies are developing and marketing seeds that are more 
tolerant to the conditions including insect and weed resistant plants in order to 
increase productivity and efficiency on the farm. Also, many firms focus on 
veterinary care, vaccines, and health supplies for livestock to promote a healthier 
and more productive herd. Bioprocessing is common among agricultural 
biotechnology firms because it deals with ways to improve foods through different 
processing methods. 
Plant and animal output characteristics obtain much less emphasis 
because these areas deal with new ideas in which firms are just beginning to 
become aware of and promote. 
There tends to be extensive fluctuation in the averages calculated. 
Average employees per firm per state, average biotech employees per firm per 
state, average revenue per firm per state, average biotech revenue per firm per 
state, average R&D per firm per state, and average biotech R&D per firm per 
state have no consistency between states (refer to Table 3 and charts in 
Appendix). This finding reveals that sizes of agricultural biotechnology firms vary 
from state to state in no particular fashion. 
Also, there are many fluctuations in the percent of average biotech 
employees to average employees, the percent of average biotech revenue to 
average revenue, and the percent of average biotech R&D to average R&D (refer 
to Table 3 in Appendix). Agricultural biotechnology companies vary from state to 
state as well as within each state. These variations create the fluctuations. 
The following table represents some data analysis to determine if 
relationships exist among the variables: 
13 
Adjusted R2 Standard Error Correlation Standard De~ation 
Tctal Oip.Jt, Feenue -0.02116887 14278.4563 0.04232385 4125597.6 
GSP, Feenue -0.01838757 14258.9983 -0. (J12.77264 160997.4 
GSP, 1\Et Fam lrK:Crre 0.2'76359:W ffi3444.2301 0.54146843 825004.5 
..k:ils, Err(;icyees 0.10~ 49874.9735 0.35875545 2895531.8 
..k:ils, Bictech Err(;icyees 0.49720787 315.0419 0.71337277 2001837.9 
Total output compared to total revenue per state showed no signs of a 
relationship (refer to Table 1 and Table 4 in Appendix). The adjusted R2 and 
correlation are very low, and the standard error and standard deviation are very 
high. There is wide scatter among these points (refer to Total Output vs. 
Revenue chart in Appendix). This proves no relationship exists between 
agricultural biotechnology companies' sales and total agricultural output. 
Gross State Product when compared to total revenue per state revealed 
no relationship (refer to Table 1 and Table 4 in Appendix). The adjusted R2 and 
the correlation were both very low, and, actually, negative. The standard error 
and standard deviation were both very high. This truly represents no relationship 
among these two variables (refer to GSP vs. Revenue chart in Appendix). 
Gross State Product and Net Farm Income have a small adjusted R2 and 
correlation. However, they have a high standard error and standard deviation. 
No true relationship exists between these two variables (refer to Table 4 and 
GSP vs. Farm Net Income chart in Appendix). The chart in the Appendix shows 
wide dispersion of points revealing little, if any, relationship. 
Jobs per state and total employees per state also show few signs of 
relationship (refer to Table 1 and Table 4 in Appendix). These have a low 
correlation and R2 and a high standard deviation and standard error. The 
dispersion of points follows a slight pattern besides several exceptions (refer to 
Jobs vs. Employees chart in Appendix). This reveals a small possibility of a 
relationship. 
Jobs per state and total biotech employees per state has a strong 
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correlation and adjusted R2• They do have a large standard error and standard 
deviation, but the correlation is surprising. Since the Jobs vs. Employees had a 
low correlation, this comparison is expected to have a low correlation. I feel that 
this is questionable and little relationship between the two variables exist. The 
dispersion of points is mainly found at the minimum points on the graph (refer to 
Table 1 and Table 4 and Jobs vs. Biotechnology Employees chart in Appendix). 
This, also, causes the relationship to be questionable. 
No relationship is found with total employees and total biotech employees. 
They have a low adjusted R2 and correlation as well as a high standard error and 
standard deviation. The dispersion of points on the graph present a varied 
scatter (refer to Table 1 and Employees vs. Biotech Employees chart in 
Appendix). 
Conclusions 
This thesis revealed no relationship between agriculture and agricultural 
biotechnology firms. These firms tend to locate in non-specific areas and are not 
dependent upon the agricultural industry of the state. 
Products of firms vary across and within states. There is no consistency 
in the location to produce specific products. 
Agricultural biotechnology is an increasingly important factor in the United 
States agricultural industry. The amount of revenue of these firms and the 
number of workers they employ reveal this importance. 
Agricultural biotechnology will have a tremendous impact on the future of 
agriculture, and the statistics studied in this thesis will grow considerably. 
Tremendous potential awaits this new technology. We will see bushels per acre 
and gains per day of livestock increase substantially. Food will be processed 
more efficiently and abundantly. Environmental conservation will increase 
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because of bioremediation practices. These opportunities will allow our diverse 
world to prosper for many years to come. 
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Chart: GSP vs. Farm Net Income 
Chart: Jobs vs. Employees 
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TABLE 1 BASIC OVERVIEW OF STATES' BIOTECHNOLOGY FIRMS 
COMPANIES STATE EMPLOYEES BTEMPLOYEE FINANCE 
3Al 220.0 
4AR 60.0 
3AZ 35.0 
81 CA 48707.0 
13 co 1255.0 
8CT 7689.0 
1 DC 15.0 
5 DE 597.0 
14 Fl 321.0 
11 GA 893.0 
2 HI 126.0 
18 lA 6072.0 
20 ll 99523.0 
7 IN 1887.0 
4 KS 1885.0 
1 KY 150.0 
36 MA 7265.0 
25 MD 3453.0 
5ME 2095.0 
15 Ml 41680.0 
17 MN 83429.0 
12 MO 84419.0 
1 MS 600.01 
5MT 
47 NC 4 
1 NO 70.0 
2 NE 200.0 
2 NH 526.0 
33 NJ 309184.0 
1 NV 923.0 
23 NY 98789.0 
20 OH 42533.0 
20K 14.0 
11 OR 427.0 
24 PA 65209.0 
1 Rl 12.0 
1 so 200.0 
4TN 99.0 
22 TX 35888.0 
5 UT 636.0 
13 VA 305.0 
14 WA 36211.0 
35 WI 5362.0 
1 wv 7.0 
573 Total 993498 
COMPANIES: number of compames per state 
STATE: state 
TYPE 
20.0 3V 
5.0 3V,1P 
5.0 3V 
2094.0 50V,25P 
253.0 5V,7P 
125.0 5V,3P 
0.0 1V 
78.0 2V,2P 
4.0 10V,4P 
240.0 7V,1P 
29.0 1V,1P 
158.0 13V,1P 
509.0 10V,4P 
2.0 6V,1P 
0.0 2V,1P 
0.0 1V 
731.0 24V,11P 
157.0 18V,7P 
65.0 3V,2P 
502.0 11V,4P 
108.0 9V,6P 
2.0 5V,6P 
0.0 1P 
126.0 4V,1P 
1576.0 31V,11P 
0.0 1V 
0.0 2V 
0.0 1V,1P 
749.0 9V,24P 
0.0 1P 
1346.0 11V,11P 
163.0 14V,6P 
9.0 2V 
48.0 6V,5P 
347.0 13V,7P 
0.0 1P 
30.0 1V 
85.0 4V 
106.0 15V,7P 
17.0 4V,1P 
41.0 13V 
~p 
,5P 
0.0 1V 
10059 359V,174P 
REVENUE 
!(millions $) 
2.00000 
0.000 
103 
14331.04400 
111.03200 
958.58000 
0.00000 
16.72500 
58.98600 
24.25900 
7.63000 
18.37100 
31355.83000 
1510.00000 
108.00000 
50.00000 
994.19400 
466.57800 
362.69400 
36095.50000 
545.34600 
27636.08000 
0.00000 
7.22000 
490.03000 
2.50000 
0.00000 
0.62800 
75402.84600 
205.12000 
22600.78500 
17062.70500 
0.00000 
53.48800 
15904.51600 
1.07000 
15.00000 
11.05000 
3249.11000 
9.29000 
5.05000 
K52000 
32200 
00000 
260738 
EMPLOYEES: number of employees of biotech firms per state 
BTEMPLOYEE: number of biotech employees of biotech firms per state 
FINANCE TYPE: how company is financed, V=private, P=public 
REVENUE: amount of revenue of biotech firms per state 
REVBT _: amount of biotech revenue of biotech firms per state 
R_DBUDGET: amount budgeted for R&D for biotech firms per state 
R_DBT _: amount budgeted for biotech R&D for biotech firms per state 
REVBT R DBUDGET R DBT 
(millions$) !(millions$) 'millions$) 
124.000 0.22000 199.00 
185.000 0.000 290.000 
100.00000 60.10000 10.0 
1448.00 644.95500 ~ 100.00000 67.69800 0.00000 87.85000 
0.000 0.000 0.000 
100.00000 12.92200 100.00000 
378.00000 8.49100 444.00000 
149.00000 11.90500 130.00000 
0.00000 0.68000 0.00000 
191.00000 115.51700 439.00000 
500.00000 1389.22500 519.00000 
200. 120.00200 200.00000 
30.00 0.30 100.00000 
100.00000 5.00000 100.00000 
347.00000 153.00800 610.00000 
559.00000 47.73700 854.00000 
100.00000 38.17000 20.00000 
400.00000 1682.6 I 324.00000 
250.00000 5.98 2.00000 
215.00000 1267.65000 0 
0.000 0.00000 0 
200.00000 10.27000 200.00000 
2424.00 159.21000 1529.00 
0.000001 0.00000 0.00000 
0.00000 0.00000 0.00000 
0.00000 0.00000 0.00000 
40.00000 6033.62000 161.00000 
0.00000 2.27000 0.00000 
495.00000 224.30600 497.00000 
364.0~00.330001 502.00000 
99.00 0.000 .00000 
130.00 15.06100 000 
350.00 66.50000 477.00000 
0.00000 0.91000 0.00000 
4.00000 14.00000 5.00000 
50.00000 12.36000 149.00000 
266.00000 
31111 15.00000 19.8 198.00000 
390.00000 5.1 60.00000 
393.00000 84.05300 .00 
634.00000 108.89600 689.00000 
0.00000 0.00000 0.00000 
11330 14308 12386 
*Note: all information not available for all firms; numbers gathered based on information given 
Source: Institute for Biotechnology Information, 2000 
TABLE 2 FIRMS PER STATE WITH PRODUCTS DEVELOPED AND MARKETED CATEGORIZED 
0) c: 0 c: :;:::; Q) 
·u; (1l 
.... 
1/) 1/) » ~ 1/) :0 ::J 0 0 0 Q) Q) 1/) == 
.E 
-·E c: -C: 0 1/) ::J, "iii w 
-
Q) 
"iii (ii:J E ~ (1l 0 _::J <1lQ) 0 (1l 0 0 -o -- - '(3 E:J Ea. E ·o .... Q) E (1l c: c: Ec: c: ::J c:Cl. ~lE a. .... ::J :0 m:J ·--1- <1lQ) ·- Q) co a. ·- a. c: ::J ·c.: lE 0 0 0 !I Q) (/) C:::C!> ~(!) -c: 0:::0 c:::w c: c: <(0 <(W as as as ::! a.._ <(_ 
AL 1 1 
AR 3 1 
AZ 1 1 1 1 
CA 9 11 14 4 8 23 19 9 5 3 
co 4 2 1 3 3 3 2 
CT 1 2 2 4 2 1 1 2 
DC 1 
13 2 1 1 2 'I 1 1 1 1 5 1 4 5 1 3 7 1 2 1 2 1 1 
lA 3 8 2 10 4 2 
IL 5 8 13 3 2 
IN 1 3 2 1 1 1 
4 
1 1 1 1 
1 4 4 8 13 4 2 
1 3 9 5 7 
4 1 1 1 
'I 4 2 3 3 I 1 1 
MN 6 5 2 1 
MO 1 1 5 8 1 5 
MS 1 
MT 2 1 2 1 1 1 2 
NC 3 15 1 17 2 10 9 2 1 
ND 1 1 1 
NE 1 1 
NH 1 
NJ 2 1 10 2 10 10 7 1 4 
NV 1 
NY 2 6 12 6 4 1 1 
OH 5 1 6 8 6 1 1 
OK 1 1 
OR 1 2 1 3 2 6 1 1 
PA 3 3 6 2 8 7 5 3 3 
Rl 1 
SD 1 
TN 1 3 1 
TX 2 3 3 10 3 6 1 2 
UT 1 1 1 3 2 1 
VI"\ 1 1 4 4 6 4 2 
WA 1 6 4 6 3 2 3 
WI 5 4 12 2 1 7 17 6 5 
wv 1 
Total 37 36 137 12 19 197 1 6 161 117 41 43 
*Note: all numbers equal the total number of firms per state that have an emphasis 1n the spec1fic product categonzat1on 
Source: Institute for Biotechnology Information, 2000 
1 
2 
18 
1 
1 
4 
1 
2 
1 
2 
8 
9 
1 
2 
1 
1 
1 
3 
1 
1 
3 
1 
2 
3 
2 
72 
TABLE 3. CALCULATIONS OF BIOTECH FIRMS PER STATE 
w 
1-
<( 
1-
C/) 
rn 
cu 
cuCU CUe.. cu 0.. cucu CUa. cu cu cu E > 0 0>>. O>:::l 0>- Cl ~~-- ~ E ... :::l cu ro.Q ~E roc: ~ cue: w 0:: 0:: '-0. '-w ... cu ~..0 '-CD cuw o..cu 1- 1- 1-~E ~~-- cu iii cu > cuo cua > ... oiii CD CD CD ~0:: > cu ~0:: ~0:: cu cu <ft. <ft. <ft. <(W <(CD <(0:: O::o. 0::0:: 
73.33333 20 2 62 0.22 99.5 27272.73 0.11 0.272727 31 452.2727 
20 5 92.5 96.66666 0.25 
11.66666 5 51.5 100 30.05 10 4414286 0.583495 0.428571 1.941748 0.332779 
16.5443 74.78571 358.2 16.9725 72.45833 581103.6 0.047372 0.121298 0.109232 4.269161 
.53846 50.6 13. 100 8.46225 99.5 143766.5 0.609716 0.524143 7.20513 11.7581 
961.125 12 319. 
15 
29.28333 3324 -+-'-0._13-'--0'-'-0-'-56'-t------+----1 
149.25 26 8.3625 100 4.307333 0.174204 11.95815 23.21622 
24.69230 4 7.37325 94.5 1.213 0.161994 12.8166 73.20692 
. 181 80 6.06475 74.5 2.97625 0.985442 12.2841 2 
63 29 7.63 0.68 1 0.460317 
337.3333 31.6oooo 3.06183 63.66667 19.25283 48.77778 9076.581 6.288o:-'::'o~81-:o:--:.o:-:::9:-'::'36=7=-=6+2=-:o:-:.7=9=-=-3-=-64~2-=.5-=-33~5::-::3-::-~8 
4976.15 84.83333 2850.53 83.33333 138.9225 64.875 572838.4 0.048735 0.017048 0.029234 0.466987 
269.5714 2 755 100 60.001 100 2800742 0.079471 0.007419 0.13245 1.666639 
471.25 54 30 0.3 100 114588.9 0.005555 0.555556 333.3333 
150 0 100 5 100 333333.3 0.1 0 2 20 
60.91666 69.4 8.500444 87.14285 266091.5 0.153901 0.293473 1.256495 10.25156 
143.875 15.7 79.85714 3.409785 85.4 231638.6 0.102313 0.109123 2.39617 25.04556 
419 21.66666 100 19.085 20 288539.4 0.157860 0.05171 0.827144 1.047943 
2977.142 83.66666 5 80 210.3262 64.8 1732030 0.040788 0.028103 0.015514 0.308093 
5214.312 21.6 68.1 50 1.1972 30.33333 0.004142 0.733479 25.3369 
7034.916 2 460 316.9125 60 0.068804 0284 0.015559 0.189327 
600 
97.08888 43.77777 25 
70 
100 
100 3.423333 100 76160.34 1.422437 1.329114 41.55125 
89.77778 7.9605 84.94444 265643.7 0.308653 0.450904 3.480 
35714.29 
263 0.628 0 2387.833 0 
9662 68.09090 3770.142 20 317.5589 53.66666 390203.1 0.084229 0.007047 0.005305 0.168997 
923 0 205.12 0 2.27 0 222231.9 0.011066 0 0 0 
4295.173 122.3636 1506.719 82.5 16.02185 62.125 350793.5 0.010633 0.028489 0.054755 3.877516 
2362.944 27.16666 2132.838 60.66667 266.7216 62. .8 0.125054 0.011497 0.028444 0.235264 
7 9 99 1.285714 
38.81818 9.6 2.151571 .281577 0.24730 
2835.173 57.833 70 29.61111 68. 0.020479 0.0203 
12 0.9'1 89166.67 0.850467 
200 30 15 4 14 5 75000 0.933333 0.15 
24.75000 42.50000 2.76250 50.00000 6.18000 74.50000 111616.2 2.237104 1.717172 
1631.272 26.5 270.7591 53.2 2.864181 52.6 0.010578 0.016245 
127.2000 17.00000 4.64500 15.00000 6.60667 99.00000 36517.3 1.422317 0.133648 
23.46153 8.2 1.01 65 1.03 93.33333 43049.18 1.019801 0.349508 
.21048 
.30126 
WA 2789.846 5.666666 991.1998 98.83333 8.393 76.33333 355288.3 0.008467 0.002031 0.099711 9.094881 
WI 162.4848 35.88888 12.22033 79.25 18.14933 76.55555 75209.06 1.485174 0.220875 6.485093 4.218092 
WJ 7 
Average Employees: Average number of employees per firm per state 
Average BTEmp: Average number of biotech employees per firm per state 
Average Revenue: Average revenue per firm per state 
Average Revbt: Average biotech revenue per firm per state 
Average RD: Average R&D per firm per state 
Average RDBT: Average biotech R&D per firm per state 
TABLE 3. CALCULATIONS OF BIOTECH FIRMS PER STATE. continued 
Revenue per Emp: Amount of revenue per employee per state (Average revenue/Average employees) 
RD per Revenue: Amount of R&D per employee per state (Average R&D/Average employees) 
%BTEmp: Percent of biotech employees compared to employees (100*Average BTEmp/Average employees) 
%BTRD: Percent of biotech R&D compared to R&D (100*Average RDBT/Average RD) 
*Note: all information not available for all firms; numbers gathered based on information given 
Source: Institute for Biotechnology Information, 2000 
TABLE 4. GENERAL DATA FOR EACH STATE 
]1 E ...... ...... ::::! fD 
fD "0 "0 0 "0 
.._ Q. ~ c J!! ...... EG> .0 c ...... c ::::! w 
. Q., .m m -- m -- 0 (ij ..... o...., ...... E Q. J!!E 1- E 0.. e Ea ~::::! -::::! <( fD Ol ]1 .._ Q. c:a. sa. ~.~ a. 1- .0 m .._ J!! 0 0 e ·c: :5 Q) ..... o-:5 (/) 0 ~ 0 m ?f. .._ ~ (/)g (/) -, 0 1- LL 0 0 0 <(o 1-0 C> 
Al 32.5 8.7 48.2 668650 2568856 1209086 09 
AR 70.0 2030191 3258444 1594954 58479 
AZ. 4.8 1347830 937631 207735 700203 121239 
39.0 17,403,988 6,934 786 1,515,322 366,042 1033016 
32.2 1,515,554 2,794,526 569 504 723 126084 
50.4 278,448 224,780 62,498 129,229 134565 
0.0 0 0 0 0 52372 
84.0 164,142 610,139 102,173 876,454 118,055 31585 
34.8 5,343,106 1,372,230 313,812 7,029,148 2,225,846 52372 
50.3 1,957,608 3,410,094 773,804 6,141,507 1,900,804 380607 
20.3 418,337 89,172 34,971 542,480 34,157 229473 
6,339,120 4,811,820 990,611 12,141,552 2,277,273 161701 
IL 6,449,458 1,583,231 736,780 8,769,469 1,483,68'1 29149 
IN 3,343,604 1,664,703 5,633,271 801,602 393532 
KS 1, 3 256,422 4,549,830 1,496,048 80479 
KY 2 1,704,298 2,115,138 1 313,038 71737 
MA 3,923, 379,305 109,451 130,282 153797 
MD 2906, 576,752 945,601 309,508 30156 
ME 747,075 227,488 2 724 62,700 124350 
Ml 5,386,527 79.9 2,115,449 308,37'1 221009 
MN 3,166,319 82.7 4,166,935 1260,353 272607 
MO 3,351 820 66.7 2,173,765 ,110 58314 
MS 1,425,691 19.2 58.7 1,166,383 926,689 149394 
MT 534,091 19.3 30.1 910,345 355,137 100 
NC 4,612,376 19.'1 29.3 3,360,359 2,361,078 651652 
NO 441,421 23.2 68.7 2,702,460 45,510 218888 
NE 1 145,953 22 .1 48.5 3 927,529 9,776,889 1,758,910 19160 
NH 735,959 13.5 0.1 32.0 78,738 175,628 11,881 57407 
NJ 4,494,373 11.9 0.6 71.5 588,973 875,619 117,366 38106 
NV 1,089,522 10.8 0.8 13.2 145,040 379,646 47,148 48812 
NY 9,908,048 12.1 24.0 4.7 65.1 1,028,438 3,397,781 447,430 45242 
OH 6,596,769 14.'1 53.8 11.3 80.4 3, 125,197 5,791,504 1,298,533 15786 
OK 1,888,739 17.2 75.6 14.8 44.7 987,617 4 336,601 900,541 320506 
OR 2,000,888 18 28.4 5.3 30.3 2,339,208 3,797,316 515,110 76642 
PA 6,693,841 14.2 25.0 5 70.2 1,265,909 4,685,961 662,070 98367 
Rl 561,073 8.3 0 46.3 55,817 73,926 24,218 339940 
so 499,301 91.3 19.4 43.6 2,146,055 4,207,509 1,158,285 93259 
TN 2.2 7.1 63.6 1,143,935 2,712,458 343,267 20186 
TX 11,238 78.3 37.7 28.7 4,373,727 4,713 439 3,125,087 146999 
UT 1,282 22.9 2.1 17.2 245,254 1,125,536 218,757 601643 
4,123 33.0 4.3 52.5 786 116 2 799 822 496,162 15214 
WA 3,363,268 16.4 6 7.9 52.1 3,531,283 5,995,826 1,050,467 211331 
WI 3,268,072 17.6 42.9 10.4 69.5 1,695 168 6,812,720 908,453 147325 
wv 864,397 14.8 22.4 1.3 38.7 69,059 529,270 34,884 38228 
Jobs: total jobs per state 
%ag jobs: percent of agricultural jobs per state 
Total land: total land area per state, in millions of acres 
Farmland: total farmland per state, in millions of acres 
%farmland: percent of farmland to total land 
Cropland: total cropland per state, in millions of acres 
TABLE 4. GENERAL DATA FOR EACH STATE, continued 
%cropland/farm: percent of cropland of total farmland 
Crop output: amount of revenue for crops per state, in thousands $ 
Animal output: amount of revenue for animals per state, in thousands $ 
Serv/forest output: amount of revenue for services and forestry per state, in thousands $ 
Total output: total revenue for agricultural sector per state, in thousands$ 
Net farm income: net income for farms per state, in thousands $ 
GSP: Gross State Product, in millions $ 
Source: FedStats, 2000 
Source: Bureau of Economic Analysis, 2000 
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